Eurazeo North America

The North American team operates under the broader Eurazeo SE investment committee, historically led by CEO Virginie Morgon at the group level. Specific regional leadership for the North American office has not been publicly named, but investment decisions follow Eurazeo's process across private equity, venture, and growth equity.

Eurazeo North America is a division of Eurazeo SE, the publicly traded French investment company. It is not a separate fund with its own LPs; rather, it deploys capital from Eurazeo's permanent capital base and from its managed fund vehicles on behalf of institutional investors. This structure allows the North American team to hold assets for indefinite periods if the investment thesis requires.

The firm targets a full spectrum including buyout, growth equity, and venture capital. It focuses on established companies with proven business models as well as earlier-growth-stage firms in the technology, healthcare, and financial services sectors. The platform is structured to lead or co-lead transactions ranging from $50 million to several hundred million dollars.

Deal sourcing leverages the Eurazeo group's 25-year track record and its network of portfolio companies, investment bankers, and industry executives across Europe and North America. The team also benefits from proprietary deal flow generated by Eurazeo's sector-focused teams in technology, healthcare, and financial services, as well as co-investment relationships with other institutional investors.

Eurazeo acquired Idinvest, a French private debt and venture capital firm, in 2018, and the combined group operates under the Eurazeo brand. Idinvest's legacy venture and private debt activities are integrated into Eurazeo's broader platform, while the North American unit focuses on direct private equity and growth investments. The group's structure encompasses multiple specialized teams under a single management umbrella.